GWLL (Goldenwell Biotech) LT-Debt-to-Total-Asset: 5.05 (As of Mar. 2026)


GWLL Goldenwell Biotech Inc GWLL
30 GF Score
Price $0.90
! 1 Warning Sign
View Full Analysis

What is Goldenwell Biotech LT-Debt-to-Total-Asset?

Goldenwell Biotech GWLL 30 LT-Debt-to-Total-Asset is 5.05 as of Mar. 2026. GuruFocus rates GWLL with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Goldenwell Biotech's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 5.05.

Goldenwell Biotech's long-term debt to total assets ratio increased from Mar. 2025 (0.50) to Mar. 2026 (5.05). It may suggest that Goldenwell Biotech is progressively becoming more dependent on debt to grow their business.

Goldenwell Biotech  (OTCPK:GWLL) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Goldenwell Biotech LT-Debt-to-Total-Asset Related Terms

Goldenwell Biotech LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Goldenwell Biotech's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Goldenwell Biotech LT-Debt-to-Total-Asset Chart

Goldenwell Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 0.00 0.00 0.42 0.43 2.67

Goldenwell Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.50 0.38 0.44 2.67 5.05
GWLL
30GF Score
Goldenwell Biotech Inc GWLL
LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Goldenwell Biotech LT-Debt-to-Total-Asset Calculation

Goldenwell Biotech's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )/Total Assets (A: Dec. 2025 )
=0.096/0.036
=

Goldenwell Biotech's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )/Total Assets (Q: Mar. 2026 )
=0.096/0.019
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 5.05 mean?
Goldenwell Biotech (GWLL) has a LT-Debt-to-Total-Asset of 5.05 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Goldenwell Biotech and its competitors.
Is Goldenwell Biotech's LT-Debt-to-Total-Asset too high?
Goldenwell Biotech's current LT-Debt-to-Total-Asset is 5.05. Overall, Goldenwell Biotech has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Goldenwell Biotech's LT-Debt-to-Total-Asset compare to HAIN and LSF?
Goldenwell Biotech's LT-Debt-to-Total-Asset of 5.05 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Consumer Packaged Goods company?
A good LT-Debt-to-Total-Asset depends on the Consumer Packaged Goods industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Goldenwell Biotech and its competitors. Goldenwell Biotech's current LT-Debt-to-Total-Asset is 5.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Goldenwell Biotech stock overvalued right now?
Goldenwell Biotech (GWLL) has a current LT-Debt-to-Total-Asset of 5.05. The current LT-Debt-to-Total-Asset is 5.05. Goldenwell Biotech's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Goldenwell Biotech (GWLL), the current LT-Debt-to-Total-Asset is 5.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Goldenwell Biotech Business Description

Address 581 Boston Mills Road, Suite 300, Hudson, OH, USA, 44236
Goldenwell Biotech Inc is engaged in the research and development, production, and sales of healthcare and supplement products. Its products comprise JI MAI - Bovine Cardiac Vascular Active Peptide, Double Proline AG - 3D Active Collagen Peptide, Cartilage Peptide - Type II collagen peptide, and Sugar Master.
30GF Score

Get the complete analysis for GWLL

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.90
Price